Stampa

W06 Ricerca farmaco

A randomized, open-label, multicenter, phase III, 2-arm study comparing efficacy and tolerability of the intensified variant ‘dose-dense/dose-intense ABVD’ (ABVD DD-DI) with an interim PET response-adapted ABVD program as upfront therapy in advanced-stage
2016-002509-21
Fondazione Italiana Linfomi ONLUS (FIL)
FIL- Rouge
04-07-2017
14-07-2017
0.00
0.00
0.00
19-02-2020 14:47:35

Pincipal investigators

Ematologia Rimini
Anna Lia Molinari